glp-1 agonists vision loss blindness Eye doctors warn drugs for diabetes and weight may pose rare risks, recommending regular checkups Frontiers | Unlocking the potential

PMID: 41032460

The addition of spironolactone as a fourth-line therapy has been shown to significantly improve blood pressure control, as demonstrated in the PATHWAY-2 trial

Rybelsus, a semaglutide pill approved in 2019, has been used to treat type 2 diabetes

Diabetes Healthcare Professionals Consider Whole Person As diabetes healthcare professionals, we want to carefully consider which medication best matches the people in our care, considering individual values and preferences along with co-conditions including diabetes, cardiorenal metabolic co-conditions, MASH, sleep apnea and weight goals

Savvy users document withdrawal times, test demo modes, and gauge volatility ranges before committing real funds, so they can align entertainment with a comfortable risk profile and a clear understanding of house edges